Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Pediatric Rheumatology · LACC1-Associated Juvenile Arthritis

Building Your Care Team

At a Glance

Children with LACC1-associated juvenile arthritis benefit from a coordinated team led by a pediatric rheumatologist, with genetics, physical and occupational therapy, eye care, and emotional support. Shared care can reduce the family's coordination workload.

Because LACC1-associated juvenile arthritis is a complex, multi-system disease, your child will need a coordinated team of specialists. Rather than bearing the entire burden as the family “project manager,” look for clinics that utilize a shared-care model. In this model, a clinic nurse, social worker, or primary care clinician helps coordinate referrals, records, school letters, and medication authorizations so the burden does not rest entirely on the family [1][2].

Your Core Care Team

A specialized team helps ensure that every aspect of the disease—from the genetic “blueprint” to the physical impact on the joints—is addressed.

  • Pediatric Rheumatologist: This is the lead doctor who will manage your child’s medications and monitor for systemic inflammation. Because LACC1 is a monogenic autoinflammatory disorder, you should look for a rheumatologist with experience in genetic immune conditions, not just general arthritis [3][1].
  • Clinical Geneticist: A geneticist or genetic counselor is essential for interpreting your child’s specific LACC1 variants. They can determine if the mutation is “homozygous” or “compound heterozygous” and coordinate testing for other family members [4][5].
  • Physical and Occupational Therapists (PT/OT): Because this condition is frequently erosive (meaning it can cause permanent bone and cartilage wear), specialized therapists are vital [6]. They focus on maintaining joint mobility, preventing “contractures,” providing pain management plans, and advising on school accommodations [7]. If lymphedema is present, a specialized lymphedema therapist is also recommended.
  • Pediatric Ophthalmologist: Children with juvenile arthritis are at risk for uveitis, which is silent inflammation inside the eye that can cause permanent vision loss [8]. While the LACC1-specific uveitis risk is uncertain, the ophthalmologist will determine your child’s specific screening interval (using a slit-lamp examination) based on their JIA phenotype, ANA status, and age [9][10]. Always seek urgent evaluation for new eye pain, redness, light sensitivity, or vision changes.
  • Psychosocial Support: A psychologist, social worker, and school-support contact can help manage the emotional toll, fatigue, and daily-life challenges of living with a chronic disease.

Preparing for Your First Appointment

Coming prepared to your first visit can help the care team make faster, more accurate treatment decisions. You should bring a physical or digital folder containing:

  • The Complete Genetic Report: Do not bring just a summary. The doctors need to see the exact genetic variants and the laboratory’s classification of those variants [11].
  • Laboratory Trends: Bring copies of blood work showing “inflammatory markers,” such as CRP (C-reactive protein), ESR (sedimentation rate), and ferritin [12][13]. Seeing how these numbers change during a flare vs. when the child is well is crucial for diagnosis.
  • Original Imaging: If your child has had X-rays or MRIs, bring the actual images (often on a CD or via a digital portal) rather than just the radiologist’s report. Rheumatologists often prefer to look at the joints themselves to assess for early signs of erosion [14][15].
  • A Treatment Timeline: Create a simple list of every medication your child has tried, the dosage, how long they took it, and whether it seemed to help.

If your local doctor has never seen a LACC1 case, they should be willing to consult with a specialist at a major academic center or a national autoinflammatory registry [16].

Common questions in this guide

Who should be part of my child's care team for LACC1-associated juvenile arthritis?
A pediatric rheumatologist usually leads care, while a clinical geneticist or genetic counselor interprets LACC1 variants. Physical and occupational therapists, a pediatric ophthalmologist, and psychosocial professionals may also be needed; a lymphedema therapist can help if persistent limb swelling occurs.
How does shared care make managing this rare disease easier?
In a shared-care model, a nurse, social worker, or primary care clinician helps coordinate referrals, medical records, school letters, and medication authorizations. This reduces the amount of administrative work the family must manage alone.
What should I bring to my child's first LACC1 arthritis appointment?
Bring the complete genetic laboratory report, including the exact LACC1 variants and their classifications, along with trends in inflammatory blood tests such as C-reactive protein, ESR (sedimentation rate), and ferritin. Also bring original X-ray or MRI files and a timeline of medicines, doses, treatment duration, and responses.
How often should my child be checked for eye inflammation?
A pediatric ophthalmologist should set the schedule for slit-lamp examinations, which are detailed eye exams, based on the child's juvenile arthritis pattern, ANA blood-test status, and age; the LACC1-specific risk of uveitis is uncertain. Seek urgent evaluation for new eye pain, redness, light sensitivity, or vision changes.
Why are physical and occupational therapy important for LACC1-associated juvenile arthritis?
The condition can wear down bone and cartilage, so physical and occupational therapists help preserve joint movement, prevent contractures (stiff joints that cannot move fully), manage pain, and plan school accommodations. A lymphedema therapist may be useful if the child has persistent limb swelling.
What can we do if our local doctor has not treated LACC1-associated juvenile arthritis before?
The local team can consult a specialist at a major academic medical center or connect with a national autoinflammatory registry. This may help clinicians access experience with rare LACC1 cases while keeping local care involved.

Get notified when new evidence is published on juvenile arthritis due to defect in LACC1.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    New or vanishing frontiers: LACC1-associated juvenile arthritis.

    Al-Mayouf SM, Yateem M, Al-Dusery H, et al.

    International journal of pediatrics & adolescent medicine 2021; (8(1)):44-47 doi:10.1016/j.ijpam.2020.11.005.

    PMID: 33718577
  2. 2

    Clinical characteristics and genotype analysis of a Chinese patient with juvenile arthritis due to novel LACC1 frameshift mutation and literature review.

    Wu Y, Wang S, Yin W, et al.

    Molecular genetics & genomic medicine 2023; (11(7)):e2175 doi:10.1002/mgg3.2175.

    PMID: 37186377
  3. 3

    A novel LACC1 variant c.658G>A (p. Asp220Asn) in familial juvenile arthritis: identification and functional analysis.

    Alblooshi H, Mustafa N, Khalam AA, et al.

    Human genomics 2025; (19(1)):85.

    PMID: 40713900
  4. 4

    Systematic genetic analysis of pediatric patients with autoinflammatory diseases.

    Poker Y, von Hardenberg S, Hofmann W, et al.

    Frontiers in genetics 2023; (14()):1065907 doi:10.3389/fgene.2023.1065907.

    PMID: 36777733
  5. 5

    Clinical and Genetic Findings of the First Report of PAPA Syndrome in Brazil.

    Fernandes SJ, Valdomir Nadaf MI, Monteiro NH, et al.

    Case reports in immunology 2021; (2021()):6660937 doi:10.1155/2021/6660937.

    PMID: 34938582
  6. 6

    [Monogenic variants in Laccase domain-containing 1 (LACC1) as the cause of juvenile arthritis].

    Knieper AM, von Stuckrad ASL, Minden K, et al.

    Zeitschrift fur Rheumatologie 2024; (83(1)):4-14 doi:10.1007/s00393-023-01442-2.

    PMID: 37921883
  7. 7

    EULAR/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update.

    Ozen S, Sağ E, Oton T, et al.

    Annals of the rheumatic diseases 2025; (84(6)):899-909 doi:10.1016/j.ard.2025.01.028.

    PMID: 40234174
  8. 8

    2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.

    Angeles-Han ST, Ringold S, Beukelman T, et al.

    Arthritis care & research 2019; (71(6)):703-716 doi:10.1002/acr.23871.

    PMID: 31021540
  9. 9

    Diagnosis and treatment of uveitis associated with juvenile idiopathic arthritis.

    Lazăr C, Spîrchez M, Ştefan M, et al.

    Medicine and pharmacy reports 2021; (94(Suppl No 1)):S28-S32 doi:10.15386/mpr-2224.

    PMID: 34527905
  10. 10

    A Nordic screening guideline for juvenile idiopathic arthritis-related uveitis.

    Leinonen S

    Acta ophthalmologica 2023; (101(4)):465-468 doi:10.1111/aos.15299.

    PMID: 36458735
  11. 11

    ISSAID/EMQN Best Practice Guidelines for the Genetic Diagnosis of Monogenic Autoinflammatory Diseases in the Next-Generation Sequencing Era.

    Shinar Y, Ceccherini I, Rowczenio D, et al.

    Clinical chemistry 2020; (66(4)):525-536 doi:10.1093/clinchem/hvaa024.

    PMID: 32176780
  12. 12

    A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.

    Özen S, Batu ED, Taşkıran EZ, et al.

    The Journal of rheumatology 2020; (47(1)):117-125 doi:10.3899/jrheum.181384.

    PMID: 31043544
  13. 13

    PAPA and FMF in two siblings: possible amplification of clinical presentation? A case report.

    Maggio MC, Ceccherini I, Grossi A, et al.

    Italian journal of pediatrics 2019; (45(1)):111 doi:10.1186/s13052-019-0705-z.

    PMID: 31443670
  14. 14

    Clinical and genetic analysis of Majeed syndrome caused by LPIN2 complex heterozygous mutation and literature review.

    Wang S, Yu T, He X, et al.

    Frontiers in pediatrics 2025; (13()):1602509 doi:10.3389/fped.2025.1602509.

    PMID: 41113563
  15. 15

    Sacroiliitis in familial Mediterranean fever: A rare joint involvement of the disease.

    Özçelik E, Çelikel E, Tekin ZE, et al.

    Journal of paediatrics and child health 2024; (60(10)):511-515 doi:10.1111/jpc.16623.

    PMID: 39051573
  16. 16

    Pattern and diagnostic evaluation of systemic autoinflammatory diseases other than familial Mediterranean fever among Arab children: a multicenter study from the Pediatric Rheumatology Arab Group (PRAG).

    Al-Mayouf SM, Almutairi A, Albrawi S, et al.

    Rheumatology international 2020; (40(1)):49-56 doi:10.1007/s00296-019-04478-3.

    PMID: 31741047

This page is for informational purposes only and does not constitute medical advice. Your child's clinicians should tailor referrals, monitoring, and treatment for LACC1-associated juvenile arthritis to the child's specific needs.